Epithelioid Inflammatory Myofibroblastic Sarcoma: A Report of a Rare Case.
Autor: | Ronanki V; Pathology, NRI Medical College, Guntur, IND., Tejeswini V; Pathology, NRI Medical College, Guntur, IND., Venkata Renuka I; Pathology, NRI Medical College, Guntur, IND., Raheema S; Pathology, NRI Medical College, Guntur, IND., S K Kanth B; Pathology, NRI Medical College, Guntur, IND. |
---|---|
Jazyk: | angličtina |
Zdroj: | Cureus [Cureus] 2024 Aug 30; Vol. 16 (8), pp. e68184. Date of Electronic Publication: 2024 Aug 30 (Print Publication: 2024). |
DOI: | 10.7759/cureus.68184 |
Abstrakt: | Epithelioid inflammatory myofibroblastic sarcoma (EIMS), a variant of inflammatory myofibroblastic tumor (IMT), is a rare malignant tumor commonly associated with anaplastic lymphoma kinase (ALK) gene fusions and is aggressive in nature with local recurrence. Here, we report a case of a 23-year-old female who presented with a cough and, upon investigations, was found to have a mass in the left upper lobe of the lung detected by chest computed tomography (CT). Biopsy revealed EIMS with ALK and desmin protein expression. The patient underwent a lobectomy via video-assisted thoracoscopic surgery (VATS). The postoperative period was uneventful. Competing Interests: Human subjects: Consent was obtained or waived by all participants in this study. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work. (Copyright © 2024, Ronanki et al.) |
Databáze: | MEDLINE |
Externí odkaz: |